GlassScriptPhysician profile
Julie Shih
NPI 1386742732
$1,667.90
in general payments reported to CMS, 2019-2025
20 companies · $396 in 2025
The $396 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $360 · 2021: $187 · 2023: $29.21 · 2024: $168 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.12 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $258.40 | 2020 | |
| Astellas Pharma US INC | $227.81 | 2019-2025 | Veozah |
| Medtronic, INC. | $144.32 | 2021 | |
| Exeltis, USA INC. | $129.03 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $114.98 | 2024-2025 | |
| Sage Therapeutics, LLC | $100.07 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $69.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $59.38 | 2019-2025 | Gardasil 9 |
| Exact Sciences Corporation | $55.01 | 2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $39.50 | 2019-2021 | |
| Pfizer INC. | $38.36 | 2019-2025 | |
| Aspira Women'S Health INC | $20.47 | 2025 | Ova1 |
| Glaxosmithkline, LLC. | $16.91 | 2025 | Nucala |
| Amag Pharmaceuticals, INC. | $16.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $14.31 | 2025 | Qelbree |
| Duchesnay USA Incorporated | $12.53 | 2019 | |
| Lupin INC. | $11.98 | 2019 | |
| Myovant Sciences INC. | $11.76 | 2021 | |
| Allergan, INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Shih listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.